Antihemophilic Factor (Human or Recombin... Clinical Trials

• Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients
  ClinicalTrials.gov Identifier: NCT00157157 - Active, not recruiting
  Hemophilia A
  
• Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
  ClinicalTrials.gov Identifier: NCT00243386 - Recruiting
  Hemophilia A
  
• Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00157105 - Completed
  Hemophilia A
  
• Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients with Hemophilia A
  ClinicalTrials.gov Identifier: NCT00157040 - Completed
  Hemophilia A
  
• Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
  ClinicalTrials.gov Identifier: NCT00577577 - Recruiting
  Myotonic Dystrophy Type 1
  
• Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901
  ClinicalTrials.gov Identifier: NCT00157053 - Completed
  Hemophilia A
  
• Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants
  ClinicalTrials.gov Identifier: NCT00056875 - Active, not recruiting
  Graft Versus Host Disease
  
• Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy
  ClinicalTrials.gov Identifier: NCT00041665 - Completed
  Stomatitis
  
• Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004699 - Active, not recruiting
  Hyperinsulinism
  
• Phase II Long Term, Randomized Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004700 - Active, not recruiting
  Hyperinsulinism
  
• Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00434239 - Recruiting
  Myelodysplasia
  
• Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004825 - Completed
  Hyperinsulinism
  
• Recombinant Human Insulin-Like Growth Factor (rhIGF-1)Treatment of Short Stature Associated with IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125190 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency; IGF-1
  
• Recombinant Human Factor IX (rFIX; BeneFIX®) in Previously Treated Patients (PTPs) with Hemophilia B
  ClinicalTrials.gov Identifier: NCT00093171 - Active, not recruiting
  Hemophilia B
  
• Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure
  ClinicalTrials.gov Identifier: NCT00225901 - Recruiting
  Liver Failure, Acute
  
• A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00351767 - Active, not recruiting
  Diabetic Foot Ulcers
  
• Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004061 - Active, not recruiting
  Leukemia; Lymphoma
  
• Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00006488 - Completed
  Parkinson Disease
  
• Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00095186 - Active, not recruiting
  Carcinoma, Renal Cell
  
• A Study to Evaluate the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduction of Oral Mucositis in Subjects with Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00131638 - Active, not recruiting
  Head and Neck Cancer
  
• Study of Recombinant Human Insulin-Like Growth Factor I in Patients with Severe Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00004419 - Recruiting
  Insulin Resistance; Hyperglycemia
  
• A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
  ClinicalTrials.gov Identifier: NCT00000842 - Completed
  HIV Infections; Peripheral Nervous System Disease
  
• Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
  ClinicalTrials.gov Identifier: NCT00351221 - Terminated
  Noonan Syndrome
  
• Recombinant Human Antithrombin (rhAT) in Patients with Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
  ClinicalTrials.gov Identifier: NCT00110513 - Recruiting
  Antithrombin III Deficiency
  
• Diet/Growth Factor Mechanisms of Gut Adaptation
  ClinicalTrials.gov Identifier: NCT00067860 - Recruiting
  Short Bowel Syndrome
  
• Recombinant Human Prolactin for Lactation Induction
  ClinicalTrials.gov Identifier: NCT00181649 - Recruiting
  Relative lactation insufficiency
  
• Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
  ClinicalTrials.gov Identifier: NCT00289536 - Active, not recruiting
  Hemophilia A
  
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding
  ClinicalTrials.gov Identifier: NCT00184548 - Recruiting
  Trauma
  
• Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting
  ClinicalTrials.gov Identifier: NCT00371215 - Active, not recruiting
  Surgical Hemostasis
  
• Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.
  ClinicalTrials.gov Identifier: NCT00245297 - Completed
  Haemophilia A
  
• Safety study of Recombinant Factor XIII (rFXIII) in Patients with Congenital Factor XIII Deficiency
  ClinicalTrials.gov Identifier: NCT00056589 - Completed
  Congenital Factor XIII deficiency
  
• Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
  ClinicalTrials.gov Identifier: NCT00262288 - Active, not recruiting
  Genetic Disorders
  
• Treatment With Recombinant Human GH in Children With Short Stature Secondary to a Long Term Corticoid Therapy
  ClinicalTrials.gov Identifier: NCT00174187 - Active, not recruiting
  Growth Retardation
  
• Recombinant Human Relaxin for the Treatment of Decompensated CHF
  ClinicalTrials.gov Identifier: NCT00406575 - Active, not recruiting
  Congestive Heart Failure (CHF)
  
• Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
  ClinicalTrials.gov Identifier: NCT00259103 - Active, not recruiting
  Labor, Induced
  
• Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00187148 - Active, not recruiting
  Human Immunodeficiency Virus; HIV Infections
  
• A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00000694 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Sequential Vaccinations in Prostate Cancer Patients
  ClinicalTrials.gov Identifier: NCT00060528 - Active, not recruiting
  Prostatic Neoplasms
  
• Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004132 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Use of NovoSeven® in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00154427 - Recruiting
  Post-operative bleeding following cardiac surgery
  
• Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children
  ClinicalTrials.gov Identifier: NCT00477152 - Recruiting
  Dehydration
  
• High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors
  ClinicalTrials.gov Identifier: NCT00571584 - Completed
  Haemophilia
  
• Effect of rFVIIa on Peri-Operative Blood Loss in Patients Undergoing Major Burn
  ClinicalTrials.gov Identifier: NCT00243243 - Recruiting
  Burns
  
• Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00098098 - Recruiting
  Recombinant Botulinum Vaccine a/B
  
• Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
  ClinicalTrials.gov Identifier: NCT00262301 - Recruiting
  Genetic Disorders
  
• Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00506519 - Recruiting
  Disseminated Intravascular Coagulation
  
• Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)
  ClinicalTrials.gov Identifier: NCT00168090 - Completed
  Von Willebrand Disease; Blood Coagulation Disorders; Blood Platelet Disorders; Hematologic Disease
  
• "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00214656 - Recruiting
  Myocardial Ischemia; Blood Coagulation Disorders; Coronary Artery Disease; Heart Valve Diseases
  
• Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?
  ClinicalTrials.gov Identifier: NCT00279552 - Completed
  Vitamin B12 Deficiency
  
• Keratinocyte Growth Factor to Prevent Acute GVHD
  ClinicalTrials.gov Identifier: NCT00031148 - Completed
  Graft-vs-Host Disease
  
• A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
  ClinicalTrials.gov Identifier: NCT00500058 - Recruiting
  B Cell Non-Hodgkin's Lymphoma
  
• A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure
  ClinicalTrials.gov Identifier: NCT00259116 - Active, not recruiting
  Heart Failure, Congestive
  
• Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)
  ClinicalTrials.gov Identifier: NCT00398749 - Recruiting
  Anemia; Neoplasms
  
• Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
  ClinicalTrials.gov Identifier: NCT00357656 - Recruiting
  Hemophilia A
  
• Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children.
  ClinicalTrials.gov Identifier: NCT00323752 - Recruiting
  Scoliosis
  
• Recombinant Human Prolactin for Lactation Induction
  ClinicalTrials.gov Identifier: NCT00181610 - Recruiting
  Lactation
  
• Recombinant Human Prolactin for Lactation Induction
  ClinicalTrials.gov Identifier: NCT00181623 - Recruiting
  Lactation
  
• Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006225 - Active, not recruiting
  Breast Cancer; Leukemia; Lymphoma; Male Breast Cancer; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm
  
• Stem Cell Factor Medication for Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001398 - Completed
  Aplastic Anemia; Pancytopenia
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00099671 - Active, not recruiting
  HIV Infections
  
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00325130 - Active, not recruiting
  Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
  
• A Multicenter Study Evaluating the Safety and Tolerability of IV Recombinant Human Mannose Binding Lectin (rhMBL) in Liver Transplant Recipients.
  ClinicalTrials.gov Identifier: NCT00415311 - Recruiting
  Liver Transplantation
  
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents
  ClinicalTrials.gov Identifier: NCT00337428 - Active, not recruiting
  Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Poliomyelitis
  
• Effects of Recombinant Human Glutamic Acid Decarboxylase . . .
  ClinicalTrials.gov Identifier: NCT00529399 - Not yet recruiting
  Type 1 Diabetes Mellitus
  
• Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) with Advate (FLrFVIII) in Hemophilia A
  ClinicalTrials.gov Identifier: NCT00141843 - Active, not recruiting
  Hemophilia A
  
• Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
  ClinicalTrials.gov Identifier: NCT00243659 - Recruiting
  Hemophilia A
  
• Growth Hormone to Increase Immune Function in People with HIV
  ClinicalTrials.gov Identifier: NCT00071240 - Active, not recruiting
  HIV Infections
  
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
  ClinicalTrials.gov Identifier: NCT00030121 - Active, not recruiting
  Respiratory Distress Syndrome
  
• Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
  ClinicalTrials.gov Identifier: NCT00377078 - Recruiting
  Clostridium Difficile
  
• Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
  ClinicalTrials.gov Identifier: NCT00225147 - Recruiting
  Hereditary Angioedema; Angioneurotic Edema
  
• A Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Patients With Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00318643 - Recruiting
  Bladder Cancer
  
• Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00367991 - Recruiting
  Myocardial Infarction
  
• Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL) in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00388999 - Recruiting
  Multiple Myeloma
  
• Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00116597 - Active, not recruiting
  Melanoma
  
• Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler
  ClinicalTrials.gov Identifier: NCT00426920 - Not yet recruiting
  Diabetes Mellitus
  
• Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
  ClinicalTrials.gov Identifier: NCT00250770 - Active, not recruiting
  Uterine Neoplasms; Endometrial Neoplasms
  
• A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Prostate Cancer Patients with Local Failure Following Radiotherapy
  ClinicalTrials.gov Identifier: NCT00096551 - Recruiting
  Prostatic Neoplasms
  
• Leptin to Treat Lipodystrophy
  ClinicalTrials.gov Identifier: NCT00025883 - Recruiting
  Lipodystrophy
  
• A Study of the Safety, Tolerability, Pharmacokinetics of Recombinant Human Mannose-Binding-Lectin (rhMBL) in MBL Deficient Pediatric Hematology/Oncology Patients With Fever and Neutropenia
  ClinicalTrials.gov Identifier: NCT00520325 - Recruiting
  Cancer; Hematologic Diseases; Fever; Neutropenia
  
• Evaluation of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Previously Treated Patients with Moderate to Severe Hemophilia B
  ClinicalTrials.gov Identifier: NCT00093210 - Completed
  Hemophilia B
  
• Efficacy Study of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVF
  ClinicalTrials.gov Identifier: NCT00565747 - Recruiting
  Infertility
  
• Study to Assess Recombinant Human Antithrombin in Patients with Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
  ClinicalTrials.gov Identifier: NCT00056550 - Completed
  Hereditary Antithrombin Deficiency
  
• rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter.
  ClinicalTrials.gov Identifier: NCT00145366 - Active, not recruiting
  Benign nontoxic and toxic goiter; Graves'' disease
  
• A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
  ClinicalTrials.gov Identifier: NCT00002263 - Completed
  HIV Infections; Cytopenias
  
• Physiologic Growth Hormone Effects in HIV Lipodstrophy
  ClinicalTrials.gov Identifier: NCT00100698 - Active, not recruiting
  AIDS; HIV Infections
  
• Recombinant Human IL-4 Receptor Used in Treatment of Asthma
  ClinicalTrials.gov Identifier: NCT00017693 - Completed
  Asthma
  
• Safety, Tolerability, and Immunogenicity of an Investigational Vaccine with Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age
  ClinicalTrials.gov Identifier: NCT00092404 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003597 - Active, not recruiting
  Brain Tumors; Musculoskeletal Tumors; Kidney Tumors; Solid Tumors
  
• A Randomized, Open-Label, Phase II, International Study of Subcutaneous Recombinant Interleukin-2 (Proleukin) With and Without Concomitant Antiretroviral Therapy in Patients with HIV-1 Infection and CD4+ Cell Counts Greater Than or Equal to 300/mm(3)
  ClinicalTrials.gov Identifier: NCT00106730 - Recruiting
  
  
• Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
  ClinicalTrials.gov Identifier: NCT00004815 - Completed
  Werner's Syndrome
  
• Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062907 - Recruiting
  Non-small cell lung cancer
  
• An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or
  ClinicalTrials.gov Identifier: NCT00002255 - Completed
  HIV Infections
  
• A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
  ClinicalTrials.gov Identifier: NCT00002126 - Completed
  HIV Infections; Cytopenias
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002817 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation
  ClinicalTrials.gov Identifier: NCT00375323 - Completed
  Hemophilia A
  
• Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
  ClinicalTrials.gov Identifier: NCT00139828 - Completed
  Hemophilia B
  
• A Multicenter, Open-Label Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00144495 - Completed
  Anemic cancer; undergoing chemotherapy
  
• A Randomized, Double-Blind Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00144482 - Completed
  Anemic cancer; undergoing chemotherapy